These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 17378239

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
    Agarwal R, Chapple P, Brown M, Szer J, Juneja S.
    Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
    Ishihara S, Nakakuma H, Kawaguchi T, Nagakura S, Horikawa K, Hidaka M, Asou N, Mitsuya H.
    Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
    [Abstract] [Full Text] [Related]

  • 26. Killer immunoglobulin-like receptor genotype in immune-mediated bone marrow failure syndromes.
    Howe EC, Wlodarski M, Ball EJ, Rybicki L, Maciejewski JP.
    Exp Hematol; 2005 Nov; 33(11):1357-62. PubMed ID: 16263420
    [Abstract] [Full Text] [Related]

  • 27. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T, Noji H.
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [Abstract] [Full Text] [Related]

  • 28. A class I MHC-restricted recall response to a viral peptide is highly polyclonal despite stringent CDR3 selection: implications for establishing memory T cell repertoires in "real-world" conditions.
    Naumov YN, Hogan KT, Naumova EN, Pagel JT, Gorski J.
    J Immunol; 1998 Mar 15; 160(6):2842-52. PubMed ID: 9510187
    [Abstract] [Full Text] [Related]

  • 29. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
    Zhang HF, Huang ZD, Wu XR, Li Q, Yu ZF.
    Life Sci; 2017 Nov 15; 189():71-75. PubMed ID: 28935248
    [Abstract] [Full Text] [Related]

  • 30. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.
    Weekes MP, Carmichael AJ, Wills MR, Mynard K, Sissons JG.
    J Immunol; 1999 Jun 15; 162(12):7569-77. PubMed ID: 10358214
    [Abstract] [Full Text] [Related]

  • 31. Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.
    Koch OM, Volkenandt M, Göker E, Buer J, Probst M, Banerjee D, Danenberg PV, Bertino JR.
    Leukemia; 1994 Jun 15; 8(6):946-52. PubMed ID: 8207989
    [Abstract] [Full Text] [Related]

  • 32. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia.
    Manz CY, Dietrich PY, Schnuriger V, Nissen C, Wodnar-Filipowicz A.
    Blood Cells Mol Dis; 1997 Jun 15; 23(1):110-22. PubMed ID: 9215756
    [Abstract] [Full Text] [Related]

  • 33. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y.
    Oncologist; 1996 Jun 15; 1(4):284-287. PubMed ID: 10388004
    [Abstract] [Full Text] [Related]

  • 34. Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia.
    Zeng W, Maciejewski JP, Chen G, Risitano AM, Kirby M, Kajigaya S, Young NS.
    Br J Haematol; 2002 Dec 15; 119(3):803-9. PubMed ID: 12437663
    [Abstract] [Full Text] [Related]

  • 35. Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.
    Fozza C, Contini S, Galleu A, Simula MP, Virdis P, Bonfigli S, Longinotti M.
    Exp Hematol; 2009 Aug 15; 37(8):947-55. PubMed ID: 19409953
    [Abstract] [Full Text] [Related]

  • 36. Long term presence of a single predominant tyrosinase-specific T-cell clone associated with disease control in a patient with metastatic melanoma.
    Ochsenreither S, Fusi A, Busse A, Letsch A, Haase D, Thiel E, Scheibenbogen C, Keilholz U.
    Int J Cancer; 2010 May 15; 126(10):2497-502. PubMed ID: 19816942
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemia.
    Piao W, Grosse J, Czwalinna A, Ivanyi P, Ganser A, Franzke A.
    Exp Hematol; 2005 Jul 15; 33(7):804-10. PubMed ID: 15963856
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.